Sandrine Lecour trained as a Doctor in Pharmacy at the University of Burgundy, France (1995) and obtained a PhD in Cardiovascular Physiology (2000) under the supervision of Prof Luc Rochette.

She is a Professor at the University of Cape Town, Leader of the Cardioprotection group at the Hatter Institute for Cardiovascular Research in Africa, University of Cape Town, South africa and co-Director of the Lionel Opie Preclinical Imaging (LOPI) Core Facility in South Africa.

Her research group focuses on the delineation of novel cardioprotective signaling pathways, including high density lipoproteins, sphingolipids and melatonin. Over the past few years, part of her research has focussed on the discovery of the Survivor Activating Factor Enhancement (SAFE) pathway.

B rated NRF researcher, she has published over 100 papers in peer-reviewed journals (H index = 34).